SciELO - Scientific Electronic Library Online

 
vol.89 issue6Treatment satisfaction and quality of life in patients with psoriasis may not be directly associated. Preliminary studyThe object of study of hygiene in the texts published in Spain in the 19th century author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Cirugía y cirujanos

On-line version ISSN 2444-054XPrint version ISSN 0009-7411

Cir. cir. vol.89 n.6 Ciudad de México Nov./Dec. 2021  Epub Feb 08, 2022

https://doi.org/10.24875/ciru.21000510 

Letters to the editor

Post-COVID-19 syndrome: Something to think about

Síndrome post COVID-19: algo en que pensar

Oscar Rojo-del Moral1  * 

1Departamento de Terapia Intensiva, Instituto Mexicano del Seguro Social, Hospital General de Zona con Medicina Familiar # 2, Saltillo, Coahuila, México


The disease caused by the new coronavirus detected in 2019 (COVID-19), which arose in the Asian continent and later spread worldwide, has generated more than 3.5 million deaths, in America, 1.6 million have been registered, and in Mexico, around 223,000, in the latter, it is equivalent to 10% of the population that suffered from COVID-19.

With the above, we must take the next step and ask ourselves: do we have to worry about the 90% who survived the acute infection? The answer is yes. The symptoms caused by COVID-19 can continue more than 4 weeks after the onset of the disease and are known as a post-COVID-19 syndrome.

The syndrome has a persistent cough, dyspnea, chest pain, and fatigue, and it may be present in one-third of survivors regardless of the severity of the initial infection1. The cause has not yet been founded; however, we know that the transforming growth factor-beta is involved. This cytokine promotes cell repair through fibrosis, which may explain the persistence of the symptoms2. It can also present with neurological disorders characterized by post-traumatic stress syndrome, neuropathy, and critically ill myopathy, especially in patients who required invasive mechanical ventilation support in intensive care units and general care wards3.

Regarding treatment, there is nothing specific but general recommendations such as identifying the syndrome and documentation of the present symptoms, leaving as a cornerstone the follow-up of patients after hospital discharge without forgetting those who kept at home.

Who can follow up? It can be done by family or general practitioner, with interventions of a pulmonary rehabilitator, and last the pulmonologist and cardiologist if there is an exacerbation of the symptoms4. It should be noted that people who have post-COVID-19 syndrome are predisposed to develop depression, anxiety, and obsessive-compulsive disorder5. Therefore, the purposeful search and evaluation by psychology and psychiatry are essential.

Finally, the post-COVID-19 syndrome can be considered as a chronic disease, which generates the need to implement strategies that include continuing education for health personnel and, above all, the dissemination of information to the general public. It is probably not enough in the months to follow, but no strategy has better results than the one that does not start with a vision for the future since this will be a large percentage of the consultation in general for a long time.

References

1. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601-15. [ Links ]

2. Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A review of persistent post-COVID syndrome (PPCs). Clin Rev Allergy Immunol. 2021. In press. doi:10.1007/s12016-021-08848-3. [ Links ]

3. Stam HJ, Stucki G, Bickenbach J, European Academy of Rehabilitation Medicine. COVID-19 and post intensive care syndrome:a call for action. J Rehabil Med. 2020;52:jrm00044. [ Links ]

4. Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. [ Links ]

5. Walitt B, Bartrum E. A clinical primer for the expected and potential post-COVID-19 syndromes. Pain Rep. 2021;6:e887. [ Links ]

FundingThe author declares that no funding was provided.

Ethical disclosures

Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data. The authors declare that no patient data appear in this article.

Right to privacy and informed consent. The authors declare that no patient data appear in this article.

Received: June 06, 2021; Accepted: July 07, 2021

* Correspondence: Oscar Rojo-del Moral Boulevard Venustiano Carranza 3458 el Kiosco C.P. 25240, Saltillo, Coah., México E-mail: oscar.rojom@imss.gob.mx

Conflicts of interest

The author declares no conflicts of interest.

Creative Commons License Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer. This is an open access article under the CC BY-NC-ND license